Zobrazeno 1 - 10
of 483
pro vyhledávání: '"Raymond Alexanian"'
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia September 2024
Autor:
Elisabet E. Manasanch, Chutima Kunacheewa, Catherine M. Claussen, Hans C. Lee, Sheeba K. Thomas, Jill Gunther, Chelsea C. Pinnix, Bouthaina S. Dabaja, Behrang Amini, Raymond Alexanian, Robert Z. Orlowski, Wenli Dong, Lei Feng, Donna M. Weber
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/4ee3174276e84addbe37e5771179400e
Autor:
Rohtesh S. Mehta, Elisabet E. Manasanch, Lei Feng, Chutima Kunacheewa, Sairah Ahmed, Donna M. Weber, Robert Z. Orlowski, Krina K. Patel, Samer Tabchi, Rajit Nair, Sheeba K. Thomas, Behrang Amini, Hans C. Lee, M.H. Qazilbash, Raymond Alexanian, Qaiser Bashir
Publikováno v:
Clin Lymphoma Myeloma Leuk
Background Multiple myeloma (MM) usually follows a clinical course leading to refractoriness and limited treatment options in advanced stages, which might need bridge therapies to either autologous stem cell transplantation or novel therapies. We rep
Autor:
Raymond Alexanian
Publikováno v:
Revista Cubana de Medicina, Vol 34, Iss 2, Pp 118-129 (1995)
Externí odkaz:
https://doaj.org/article/b4361b4cc9d34b30ae95bce5647d6bdf
Autor:
Sheeba K. Thomas, Jatin J. Shah, Donna M. Weber, Ashley Morphey, Hans C. Lee, Robert Z. Orlowski, Michael L. Wang, Emily Wesson, Ralph J. Johnson, Lei Feng, Raymond Alexanian
Publikováno v:
American Journal of Hematology. 94
Autor:
Larry W. Kwak, Luis O. Rustveld, Yiming Chen, Jialei Wang, Kay Delasalle, Michael Wang, Fanglin Li, Raymond Alexanian, Haijun Wang, Xianglin L. Du
Publikováno v:
Cancer. 118:3793-3800
Waldenstrom macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL) subtype. Little is known about the incidence and trends for this disease in the United States.Twenty-year data from the Surveillance, Epidemiology, and End Results (SEER) program were
Autor:
Isidora Arzu, Ferial Shihadeh, Valerie Klairisa Reed, L. Jeffery Medeiros, Raymond Alexanian, Jatin P. Shah, Sheeba K. Thomas, Bouthaina S. Dabaja, Robert Z. Orlowski, Donna M. Weber, Ali Mazloom, Chul S. Ha
Publikováno v:
Cancer. 117:4468-4474
BACKGROUND: The objective of this study was to review the outcome of patients with solitary plasmacytoma (SP) after definitive radiation therapy. METHODS: The authors retrospectively reviewed 84 patients with SP who were diagnosed and treated at The
Autor:
Rohtesh S. Mehta, Samer Tabchi, Ranjit Nair, Krina K. Patel, Sheeba K. Thomas, Elisabet E. Manasanch, Lei Feng, Raymond Alexanian, Muzaffar H. Qazilbash, Robert Z. Orlowski, Behrang Amini, Donna M. Weber, Sairah Ahmed, Hans C. Lee, Qaiser Bashir
Publikováno v:
Journal of Clinical Oncology. 36:8044-8044
8044Background: MM follows a clinical course leading to refractoriness and limited treatment options in RRMM. Aggressive NDMM needs rapid cytoreduction for disease control, which may not be possibl...
Autor:
Bart Barlogie, Raymond Alexanian
Publikováno v:
European Journal of Haematology. 43:84-87
Publikováno v:
Hematology. 12:235-239
In a previous trial among 137 previously untreated patients with multiple myeloma, the combination of thalidomide-dexamethasone induced remission in 66% of patients, including complete remission in 13%. In an attempt to induce more frequent remission